NASDAQ:SXTC | Cash Flow Statement | China SXT Pharmaceuticals, Inc.

Complete source-backed cash-flow history.

Available history
2017-03-31 to 2026-03-31
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-03-31-$6.21M$73,668.00-$4.02M-$1.25M$14.43M
2025-03-31-$3.3M$82,297.00-$2.35M$2,023.00$63,516.00$8.4M
2024-03-31-$3.1M$203,247.00-$1.93M$7,063.00$26,423.00-$2.62M
2023-03-31-$5.93M$250,162.00-$80,757.00-$12,303.00$2.94M
2022-03-31-$5.74M$320,007.00$268,293.00-$46,909.00$1.6M
2021-03-31-$2.75M$345,414.00-$1.32M-$5.81M$12.41M
2020-03-31-$10.29M$331,837.00$934,247.00$130,839.00-$5.5M$3.02M
2019-03-31$1.54M$180,917.00$239,192.00$535,825.00-$610,085.00$9.04M
2018-03-31$1.19M$129,439.00$1.92M$436,017.00-$1.05M-$314,216.00
2017-03-31$1.19M$293,042.00$179,176.00-$186,308.00-$50,560.00

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.